As of today (2024-05-25), Acino Holding AG's current share price is €93.92. Acino Holding AG's E10 for the fiscal year that ended in Dec13 was €3.42. Acino Holding AG's Shiller PE Ratio for today is 27.46.
The historical rank and industry rank for Acino Holding AG's Shiller PE Ratio or its related term are showing as below:
FRA:S3H'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 3.09 Med: 8.34 Max: 15.3
Current: 15.19
During the past 11 years, Acino Holding AG's highest Shiller PE Ratio was 15.30. The lowest was 3.09. And the median was 8.34.
FRA:S3H's Shiller PE Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 24.7
vs FRA:S3H: 15.19
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Acino Holding AG's adjusted earnings per share data of for the fiscal year that ended in Dec13 was €-4.210. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €3.42 for the trailing ten years ended in Dec13.
Shiller PE for Stocks: The True Measure of Stock Valuation
Acino Holding AG Shiller PE Ratio Historical Data
The historical data trend for Acino Holding AG's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acino Holding AG's Shiller PE Ratio
For the Drug Manufacturers - General subindustry, Acino Holding AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acino Holding AG's Shiller PE Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Acino Holding AG's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Acino Holding AG's Shiller PE Ratio falls into.
Acino Holding AG Shiller PE Ratio Calculation
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acino Holding AG's E10 for the fiscal year that ended in Dec13 is calculated as:
For example, Acino Holding AG's adjusted earnings per share data for the fiscal year that ended in Dec13 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Acino Holding AG (FRA:S3H) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Acino Holding AG Shiller PE Ratio Related Terms
Thank you for viewing the detailed overview of Acino Holding AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:S3H has been successfully added to your 